The House Resolution introduced by Representatives Malagari and others recognizes June 2025 as "Scleroderma Awareness Month" and June 29, 2025, as "World Scleroderma Day" in Pennsylvania. Scleroderma is identified as a rare autoimmune disease that causes skin hardening and tightening, potentially affecting various internal organs. The resolution highlights the prevalence of the disease, noting that approximately 300,000 individuals in the U.S. are affected, with a significant portion being women and African Americans. It also outlines the symptoms, diagnostic methods, and treatment options available for those diagnosed with scleroderma.

The resolution emphasizes the importance of raising awareness about scleroderma to enhance public knowledge of its symptoms and promote research for effective treatments. It acknowledges the ongoing research efforts by institutions such as Thomas Jefferson University and the University of Pennsylvania, which aim to improve the quality of life for individuals living with this condition. By designating June as Scleroderma Awareness Month, the resolution seeks to foster understanding and support for those affected by this rare disease.